Elsevier Releases Medical Board Reviews Apps

Test preparation tools for iPad help prepare for certification and re-certification exams in Cardiology, Emergency Medicine, Sleep Medicine and Surgery

Philadelphia, November 29, 2012Elsevier, a world-leading provider of scientific, technical and medical information products and services, has released four new Medical Board Reviews Apps based on content from Elsevier’s popular medical board review titles:

Accessed via iPad through Apple’s App Store, customers can first download the free Medical Board Review app, which gives a free sample of content from each app.  Customers can then purchase any of the full apps via in-app purchase.  

“Studying for certification and recertification, particularly for medical board exams, is becoming increasingly mobile, and thus it is vital that we provide immediate access to this information at the user’s fingertips,” said Robert Sheehan, Mobile Product Director at Elsevier.  “The Medical Board Reviews apps provide invaluable information in a format that is practical, convenient and comprehensive.”

Core competencies can be tested to remedy weak areas through definitive explanations for questions that are not answered correctly.  The new mobile-optimized features include:

For more information, visit the iTunes store, http://itunes.apple.com/app/medical-board-reviews/id561681397?mt=8

 

# # #

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1 212 633 3164
c.capot@elsevier.com